Literature DB >> 3733744

Fusion activity of influenza virus. A comparison between biological and artificial target membrane vesicles.

T Stegmann, D Hoekstra, G Scherphof, J Wilschut.   

Abstract

We have investigated the pH-dependent fusion activity of influenza virus toward human erythrocyte ghosts, utilizing a recently developed fluorescence assay, which permits continuous monitoring of the fusion reaction. The rate of fusion is negligible at neutral pH but shows a sharp increase at pH values just below 5.5. This pH dependence profile closely corresponds to that of virus-induced hemolysis. Fusion is rapidly inactivated by a low-pH preincubation of the virus alone either at 37 or at 0 degrees C. The presence of ghosts during this low-pH preincubation, carried out at 0 degree C under which condition there is hardly any fusion, causes a significant protection of the viral fusion activity against inactivation. Fusion initiated at low pH can be arrested instantaneously by readjustment of the pH to neutral. The characteristics of fusion of influenza virus with ghosts deviate from those of fusion with cardiolipin liposomes (Stegmann, T., Hoekstra, D., Scherphof, G., and Wilschut, J. (1985) Biochemistry 24, 3107-3113). Fusion with ghosts is consistent with a requirement of the well-documented pH-dependent conformational change in the viral hemagglutinin, whereas fusion with cardiolipin liposomes does not exhibit a strict dependence on the conformational change. Rather, the negative surface charge on the liposomes plays a critical role, as zwitterionic liposomes containing gangliosides show fusion behavior similar to that of erythrocyte ghosts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3733744

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes.

Authors:  J M Smit; R Bittman; J Wilschut
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Role of hemagglutinin surface density in the initial stages of influenza virus fusion: lack of evidence for cooperativity.

Authors:  S Günther-Ausborn; P Schoen; I Bartoldus; J Wilschut; T Stegmann
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  A host-guest system to study structure-function relationships of membrane fusion peptides.

Authors:  X Han; L K Tamm
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

4.  The influenza hemagglutinin fusion domain is an amphipathic helical hairpin that functions by inducing membrane curvature.

Authors:  Sean T Smrt; Adrian W Draney; Justin L Lorieau
Journal:  J Biol Chem       Date:  2014-11-14       Impact factor: 5.157

5.  Kinetics of influenza virus fusion with the endosomal and plasma membranes of cultured cells. Effect of temperature.

Authors:  I Nunes-Correia; S Nir; M C Pedroso de Lima
Journal:  J Membr Biol       Date:  2003-09-01       Impact factor: 1.843

Review 6.  Membrane fusion of enveloped viruses: especially a matter of proteins.

Authors:  D Hoekstra
Journal:  J Bioenerg Biomembr       Date:  1990-04       Impact factor: 2.945

7.  Intermonomer disulfide bonds impair the fusion activity of influenza virus hemagglutinin.

Authors:  G W Kemble; D L Bodian; J Rosé; I A Wilson; J M White
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

8.  pH-dependence of intermediate steps of membrane fusion induced by the influenza fusion peptide.

Authors:  Ding-Kwo Chang; Shu-Fang Cheng
Journal:  Biochem J       Date:  2006-06-15       Impact factor: 3.857

9.  Delay time for influenza virus hemagglutinin-induced membrane fusion depends on hemagglutinin surface density.

Authors:  M J Clague; C Schoch; R Blumenthal
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

10.  Reversible conformational changes and fusion activity of rabies virus glycoprotein.

Authors:  Y Gaudin; C Tuffereau; D Segretain; M Knossow; A Flamand
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.